Warning letter
Milk Specialties Global - Wautoma [ARCHIVED]: warning letter of Dec 19, 2011
FDA warning letter UCM284389 · Minneapolis District Office
Key facts
| Reference number | UCM284389 |
|---|---|
| Company | Milk Specialties Global - Wautoma [ARCHIVED] |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Dec 19, 2011 |
| Posted date | Dec 19, 2011 |
| Issuing office | Minneapolis District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.260(g), 111, 111.73, 111.70(b)(2), 111.70(e), 111.83(b)(4), 111.140(b)(3), 111.140(b)(3)(i), 111.140(b)(3)(ii), 111.140(b)(3)(iv), 111.140(b)(3)(v), 111.140(b)(3)(vi) and 4 more |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: